These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25470455)

  • 21. Adsorption onto aluminum hydroxide adjuvant protects antigens from degradation.
    Colaprico A; Senesi S; Ferlicca F; Brunelli B; Ugozzoli M; Pallaoro M; O'Hagan DT
    Vaccine; 2020 Apr; 38(19):3600-3609. PubMed ID: 32063436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Formulation and Suspension Properties on Redispersion of Aluminum-Adjuvanted Vaccines.
    Langford A; Horwitz T; Adu-Gyamfi E; Wiley C; Holding E; Zimmermann D; Ignatius AA; Ohtake S
    J Pharm Sci; 2020 Apr; 109(4):1460-1466. PubMed ID: 31930978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins.
    Heimlich JM; Regnier FE; White JL; Hem SL
    Vaccine; 1999 Jul; 17(22):2873-81. PubMed ID: 10438058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants.
    Hassett KJ; Vance DJ; Jain NK; Sahni N; Rabia LA; Cousins MC; Joshi S; Volkin DB; Middaugh CR; Mantis NJ; Carpenter JF; Randolph TW
    J Pharm Sci; 2015 Feb; 104(2):627-39. PubMed ID: 25581103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.
    Richards RL; Alving CR; Wassef NM
    J Pharm Sci; 1996 Dec; 85(12):1286-9. PubMed ID: 8961140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aluminum hydroxide adjuvant produced under constant reactant concentration.
    Yau KP; Schulze DG; Johnston CT; Hem SL
    J Pharm Sci; 2006 Aug; 95(8):1822-33. PubMed ID: 16795021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An intrinsic fluorescence method for the determination of protein concentration in vaccines containing aluminum salt adjuvants.
    Nouchikian L; Roque C; Song JY; Rahman N; Ausar SF
    Vaccine; 2018 Sep; 36(38):5738-5746. PubMed ID: 30107994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering the hydroxyl content on aluminum oxyhydroxide nanorod for elucidating the antigen adsorption behavior.
    Yu G; Liang Z; Yu Z; Li M; Yang W; Zhang Y; Zhao Y; Yang C; Xue C; Shi L; Sun B
    NPJ Vaccines; 2022 Jun; 7(1):62. PubMed ID: 35739192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solubilization of aluminum-containing adjuvants by constituents of interstitial fluid.
    Seeber SJ; White JL; Hem SL
    J Parenter Sci Technol; 1991; 45(3):156-9. PubMed ID: 1886045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvants.
    Vessely C; Estey T; Randolph TW; Henderson I; Nayar R; Carpenter JF
    J Pharm Sci; 2007 Sep; 96(9):2375-89. PubMed ID: 17518359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.
    Berthold I; Pombo ML; Wagner L; Arciniega JL
    Vaccine; 2005 Mar; 23(16):1993-9. PubMed ID: 15734073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of thermal treatment during the preparation of aluminum hydroxide adjuvant on the protein adsorption capacity during aging.
    Dandashli EA; Zhao Q; Yitta S; Morefield GL; White JL; Hem SL
    Pharm Dev Technol; 2002 Nov; 7(4):401-6. PubMed ID: 12503522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response.
    Noe SM; Green MA; HogenEsch H; Hem SL
    Vaccine; 2010 Apr; 28(20):3588-94. PubMed ID: 20211692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.
    Clapp T; Munks MW; Trivedi R; Kompella UB; Braun LJ
    Vaccine; 2014 Jun; 32(30):3765-71. PubMed ID: 24856785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of aluminium-containing adjuvants.
    White JL; Hem SL
    Dev Biol (Basel); 2000; 103():217-28. PubMed ID: 11214239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the adjuvanticity of aluminum salts and their combination in hepatitis B recombinant protein vaccine in assessed mice.
    Mahboubi A; Fazeli MR; Dinarvand R; Samadi N; Sharifzadeh M; Ilka H; Azadi S; Soleimanian R; Kalkouei H; Hajikhanmirzaei R; Valadkhani M
    Iran J Immunol; 2008 Sep; 5(3):163-70. PubMed ID: 18791283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphology and protein adsorption of aluminum phosphate and aluminum hydroxide and their potential catalytic function in the synthesis of polymeric emulsifiers.
    Cheng YJ; Huang CY; Ho HM; Huang MH
    Colloids Surf A Physicochem Eng Asp; 2021 Jan; 608():125564. PubMed ID: 32929307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.
    Iyer V; Hu L; Liyanage MR; Esfandiary R; Reinisch C; Meinke A; Maisonneuve J; Volkin DB; Joshi SB; Middaugh CR
    J Pharm Sci; 2012 Sep; 101(9):3078-90. PubMed ID: 22538529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of particle size and antigen binding on effectiveness of aluminum salt adjuvants in a model lysozyme vaccine.
    Clausi A; Cummiskey J; Merkley S; Carpenter JF; Braun LJ; Randolph TW
    J Pharm Sci; 2008 Dec; 97(12):5252-62. PubMed ID: 18398901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between protein adsorptive capacity and the X-ray diffraction pattern of aluminium hydroxide adjuvants.
    Masood H; White JL; Hem SL
    Vaccine; 1994 Feb; 12(2):187-9. PubMed ID: 8147102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.